After all, Pfizer spent more than $100 billion just to acquire the formula of Alcilan's anti-cancer drug, and it is unknown how many billions were spent on subsequent marketing expenses.

If there is any problem with the Elshelan anti-cancer drug, not only will the $120 billion be wasted, but the company's stock price will also plummet, which is the biggest loss.

Pfizer Group is also a competitor of other pharmaceutical giants.

If the future development strategy is not successful, other pharmaceutical giants will have the opportunity to take over Pfizer's market.

The size of the market is fixed. If someone eats one more bite, someone will eat one less bite. If someone eats one less bite, it means there will be one more bite of food in the market.

Similarly, if Chen Xuan loses, these pharmaceutical giants can also make a lot of profits.

He is now at the peak of his career, and his development momentum is too fierce. Antai Pharmaceutical Group has posed a great threat to these pharmaceutical giants.

If this lawsuit can break his development trend and make his development speed less unstoppable, these pharmaceutical giants will have the opportunity to breathe a sigh of relief.

Sometimes if development is interrupted all of a sudden, it will be difficult to have such an unstoppable situation in the future, and it will be difficult to develop again.

This is especially true for scientific researchers.

Chen Xuan’s current R&D capabilities are so strong that he can develop various world-class medical achievements at any time.

If he ends up being embroiled in lawsuits and exhausted from dealing with lawsuits and market opinions, it will be difficult for him to have the energy to develop new medical results.

For all pharmaceutical giants, they do not want Chen Xuan to have any new medical achievements that will compete with their drugs.

Therefore, to a certain extent, many pharmaceutical giants actually hope that Chen Xuan loses the lawsuit.

Relatively speaking, Pfizer is indeed a giant, with its various assets far exceeding those of Aetna Pharmaceuticals.

But for pharmaceutical groups, the threat posed by Antai Pharmaceutical Hotel is far greater than that of Pfizer.

Although Pfizer is huge and difficult to deal with, it will not pose too much of a threat, and the two sides can still ensure a certain degree of harmonious development.

But Chen Xuan and Antai Pharmaceutical Group are different. This is a brand new opponent. All pharmaceutical giants are unfamiliar with them, and they don’t know what other tricks the opponent has.

"Mr. Chen, this is the lawsuit information about you and Pfizer."

"I have collected some materials and analyzed some possible actions they might take."

"This time, in addition to sending lawyers from headquarters, Pfizer also collaborated with top domestic law firms to form the most powerful legal team."

After Zhang San came in, he reported seriously.

His attitude is also rare and serious.

He certainly takes this lawsuit very seriously.

This was the first major lawsuit he had fought since taking over the position of legal director of Antai Pharmaceutical Group.

There had been many legal disputes in the past, but they were all minor ones that didn't even require his involvement.

Therefore, this lawsuit against Pfizer was his first tough battle after becoming the general counsel, and also the strongest legal team he had ever faced.

Not only top international lawyers, but also top domestic lawyers have joined in.

The strength of such a team is unquestionable.

……

……

Chen Xuan just nodded at Zhang San's words and was not surprised.

The laws of each country have some subtle differences, and it is impossible for a lawyer to be proficient in the laws and regulations of all countries.

If you are suing locally, it is best to hire a local lawyer. In addition to being more familiar with local laws, they also have stronger network resources.

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like